Radiation recall dermatitis and pneumonitis in a patient treated with paclitaxel

110Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background. Radiation recall refers to a tissue reaction produced by a chemotherapeutic agent in a previously irradiated field that would not occur in a nonirradiated field. A number of agents have been reported to cause radiation recall. Recently, there have been case reports of recall dermatitis from paclitaxel treatment. Methods. A patient with metastatic lung cancer received palliative radiation to her mediastinum and ribs. Because of disease progression, she subsequently received paclitaxel. Results. After paclitaxel administration, the patient became acutely dyspneic. A subsequent chest X‐ray revealed a parenchymal opacity in a region that corresponded with the patient's radiation portal. She also developed a severe skin reaction in the previously treated electron field. Conclusions. This is one of few reported cases of recall dermatitis from paclitaxel and is also suggestive of recall pneumonitis, a phenomenon previously unreported to the authors' knowledge. Given paclitaxel's ability to function as a radiosensitizer, this response is not unexpected. As the frequency of paclitaxel administration increases, its potential as a radiation sensitizer and radiation recall should be considered. Cancer 1995;76: 1069–72. Copyright © 1995 American Cancer Society

Cite

CITATION STYLE

APA

Schweitzer, V. G., Juillard, G. J. F., Bajada, C. L., & Parker, R. G. (1995). Radiation recall dermatitis and pneumonitis in a patient treated with paclitaxel. Cancer, 76(6), 1069–1072. https://doi.org/10.1002/1097-0142(19950915)76:6<1069::AID-CNCR2820760623>3.0.CO;2-7

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free